Area of research
Molecular Biology · Physiology
Research interest
Research interests include Cell biology, Mitochondrion, Potassium channel, Biology, Chemistry, and Ceramide.
Amitriptyline inhibits Plasmodium development in infected red blood cells by modulating sphingolipid metabolism and glucose uptake
BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway
Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivo
Inhibition of a Mitochondrial Potassium Channel in Combination with Gemcitabine and Abraxane Drastically Reduces Pancreatic Ductal Adenocarcinoma in an Immunocompetent Orthotopic Murine Model
The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesis
Mitochondrial K+ channels and their implications for disease mechanisms
Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects
P. aeruginosa Induced Lipid Peroxidation Causes Ferroptotic Cell Death in Airways
Acid sphingomyelinase promotes SGK1-dependent vascular calcification
Voltage-Gated Potassium Channels as Regulators of Cell Death
Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro
Acid ceramidase of macrophages traps herpes simplex virus in multivesicular bodies and protects from severe disease
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family
Anxiety and Depression Are Related to Higher Activity of Sphingolipid Metabolizing Enzymes in the Rat Brain
Antidepressants act by inducing autophagy controlled by sphingomyelin–ceramide
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo
Targeting the Potassium Channel Kv1.3 Kills Glioblastoma Cells
Enhancement of endothelial permeability by free fatty acid through lysosomal cathepsin B-mediated Nlrp3 inflammasome activation
<i>Pseudomonas aeruginosa</i> Pyocyanin Induces Neutrophil Death <i>via</i> Mitochondrial Reactive Oxygen Species and Mitochondrial Acid Sphingomyelinase
Pharmacological targeting of ion channels for cancer therapy: In vivo evidences
Early effects of the antineoplastic agent salinomycin on mitochondrial function
Engineered liposomes sequester bacterial exotoxins and protect from severe invasive infections in mice
Sphingoid long chain bases prevent lung infection by Pseudomonas aeruginosa
Interclonal gradient of virulence in the <scp> <i>P</i> </scp> <i>seudomonas aeruginosa</i> pangenome from disease and environment
Mitochondrial ion channels as oncological targets
Targeting a mitochondrial potassium channel to fight cancer
Loss of Cystic Fibrosis Transmembrane Conductance Regulator Impairs Lung Endothelial Cell Barrier Function and Increases Susceptibility to Microvascular Damage from Cigarette Smoke
Intracellular ion channels and cancer
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia